Other Proteins

Recombinant Human GSDMD-N

Based on protein domains known to possess an affinity for ubiquitin, Tandem Ubiquitin Binding Entities (TUBEs) have been developed for the isolation and identification of ubiquitylated proteins. TUBEs display up to a 1000-fold increase in affinity for polyubiquitin moieties over the single ubiquitin binding associated domain (UBA). In addition, TUBEs display a protective effect on polyubiquitinated proteins, allowing for detection at relatively low abundance. These properties effectively “capture” protein in its polyubiquitinated state. TUBEs can be used to isolate, enrich, and identify ubiquitinated proteins from cell and tissue extracts. Magnetic beads coupled to TUBE 2 allow for efficient recovery of polyubiquitinated proteins in a single step without centrifuge. The magnetic TUBEs allows more complete removal of the unbound supernatant, which leads to lower background. Polyubiquitinated proteins can easily be separated from TUBEs for proteomic studies or identification by Western b

Recombinant human CD235a, also known as GYPA (Glycophorin A), encompassing amino acids 20-91. This construct contains a C-terminal Avi-Tag™, followed by an His-tag (6xHis). This protein was affinity purified.

Recombinant human CD235a, also known as GYPA (Glycophorin A), encompassing amino acids 20-91. This construct contains a C-terminal Avi-Tag™, followed by an His-tag (6xHis). This protein was affinity purified.

Recombinant human CLEC2D (C-type lectin domain family 2 member D), encompassing amino acids 60-191(end). This construct contains a N-terminal His-tag (6xHis) followed by an Avi-tag™. This protein was affinity purified.

Recombinant human CLEC2D (C-type lectin domain family 2 member D), encompassing amino acids 60-191(end). This construct contains a N-terminal His-tag (6xHis) followed by an Avi-tag™. This protein was affinity purified.

VEGF Blocker is a fusion protein composed of the extracellular domain that binds to VEGF (vascular endothelial growth factor) of VEGFR1 (vascular endothelial growth factor receptor 1), the extracellular domain that binds to VEGF of VEGFR2 and the Fc domain of human IgG1. This protein was affinity purified. VEGF Blocker is similar to Aflibercept.

VEGF Blocker is a fusion protein composed of the extracellular domain that binds to VEGF (vascular endothelial growth factor) of VEGFR1 (vascular endothelial growth factor receptor 1), the extracellular domain that binds to VEGF of VEGFR2 and the Fc domain of human IgG1. This protein was affinity purified. VEGF Blocker is similar to Aflibercept.

VEGF Blocker is a fusion protein composed of the extracellular domain that binds to VEGF (vascular endothelial growth factor) of VEGFR1 (vascular endothelial growth factor receptor 1), the extracellular domain that binds to VEGF of VEGFR2 and the Fc domain of human IgG1. This protein was affinity purified. VEGF Blocker is similar to Aflibercept.